Literature DB >> 19724233

Flow assessment through four heart valves simultaneously using 3-dimensional 3-directional velocity-encoded magnetic resonance imaging with retrospective valve tracking in healthy volunteers and patients with valvular regurgitation.

Stijntje D Roes1, Sebastiaan Hammer, Rob J van der Geest, Nina Ajmone Marsan, Jeroen J Bax, Hildo J Lamb, Johan H C Reiber, Albert de Roos, Jos J M Westenberg.   

Abstract

OBJECTIVES: To validate 3-dimensional (3D) 3-directional velocity-encoded (VE) magnetic resonance imaging (MRI) for flow assessment through all 4 heart valves simultaneously with retrospective valve-tracking during off-line analysis in healthy volunteers and in patients with valvular regurgitation.
MATERIAL AND METHODS: Three-dimensional 3-directional VE MRI was performed in 22 healthy volunteers and in 29 patients with ischemic cardiomyopathy who were suspected of valvular regurgitation and net flow volumes through the 4 heart valves were compared. Furthermore, the analysis was repeated for each valve in 10 healthy volunteers and in 10 regurgitant valves to assess intra- and interobserver agreement for assessment of respectively net flow volumes and regurgitation fraction.
RESULTS: In healthy volunteers, the average net flow volume through the mitral valve, tricuspid valve, aortic valve, and pulmonary valve was 85 +/- 20 mL, 85 +/- 21 mL, 83 +/- 19 mL, 82 +/- 21 mL, respectively. Strong correlations between net flow volumes through the 4 heart valves were observed (intraclass correlation coefficients [ICC] 0.93-0.95) and the coefficient of variance (CV) was small (6%-9%). The repeated analysis by the same observer and by a second observer yielded good agreement for measurement of net flow volumes (ICC: 0.93-0.99 and CV: 3%-7%). Strong correlations between the net flow volumes through the 4 heart valves were also observed in the patients with valvular regurgitation (ICC: 0.85-0.95 and CV: 7%-18%). The average net flow volume through the mitral valve, tricuspid valve, aortic valve, and pulmonary valve was 63 +/- 20 mL, 63 +/- 20 mL, 63 +/- 20 mL, 63 +/- 20 mL, respectively. Furthermore, the intra- and interobserver agreement for assessment of regurgitation fraction was good (ICC: 0.86 and 0.85, CV: 12% and 13%).
CONCLUSIONS: Flow assessment using 3D 3-directional VE MR with retrospective valve-tracking during off-line analysis enables accurate quantification of net flow volumes through 4 heart valves within a single acquisition in healthy volunteers and in patients with valvular regurgitation.

Entities:  

Mesh:

Year:  2009        PMID: 19724233     DOI: 10.1097/RLI.0b013e3181ae99b5

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  49 in total

1.  In vivo and in vitro validation of aortic flow quantification by time-resolved three-dimensional velocity-encoded MRI.

Authors:  Fabian Rengier; Michael Delles; Roland Unterhinninghofen; Sebastian Ley; Matthias Müller-Eschner; Sasan Partovi; Philipp Geisbüsch; Rüdiger Dillmann; Hans-Ulrich Kauczor; Hendrik von Tengg-Kobligk
Journal:  Int J Cardiovasc Imaging       Date:  2012-02-24       Impact factor: 2.357

2.  Three-dimensional phase contrast magnetic resonance imaging validated to assess pulmonary artery flow in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Masateru Kawakubo; Hiroshi Akamine; Yuzo Yamasaki; Atsushi Takemura; Kohtaro Abe; Kazuya Hosokawa; Junji Morishita; Michinobu Nagao
Journal:  Radiol Phys Technol       Date:  2016-10-25

3.  Evaluation of valvular insufficiency and shunts with parallel-imaging compressed-sensing 4D phase-contrast MR imaging with stereoscopic 3D velocity-fusion volume-rendered visualization.

Authors:  Albert Hsiao; Michael Lustig; Marcus T Alley; Mark J Murphy; Shreyas S Vasanawala
Journal:  Radiology       Date:  2012-08-24       Impact factor: 11.105

4.  Left Atrial 4-Dimensional Flow Magnetic Resonance Imaging: Stasis and Velocity Mapping in Patients With Atrial Fibrillation.

Authors:  Michael Markl; Daniel C Lee; Jason Ng; Maria Carr; James Carr; Jeffrey J Goldberger
Journal:  Invest Radiol       Date:  2016-03       Impact factor: 6.016

Review 5.  Valvular heart disease: diagnosis and management.

Authors:  Kameswari Maganti; Vera H Rigolin; Maurice Enriquez Sarano; Robert O Bonow
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

Review 6.  4D flow imaging: current status to future clinical applications.

Authors:  Michael Markl; Susanne Schnell; Alex J Barker
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

7.  Direct measurement of aortic regurgitation with phase-contrast magnetic resonance is inaccurate: proposal of an alternative method of quantification.

Authors:  Yoichi Iwamoto; Akio Inage; George Tomlinson; Kyong Jin Lee; Lars Grosse-Wortmann; Mike Seed; Andrea Wan; Shi-Joon Yoo
Journal:  Pediatr Radiol       Date:  2014-06-18

8.  The Impact of Cardiac Motion on Aortic Valve Flow Used in Computational Simulations of the Thoracic Aorta.

Authors:  David C Wendell; Margaret M Samyn; Joseph R Cava; Mary M Krolikowski; John F LaDisa
Journal:  J Biomech Eng       Date:  2016-09-01       Impact factor: 2.097

Review 9.  Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance.

Authors:  Michael Markl; Philip J Kilner; Tino Ebbers
Journal:  J Cardiovasc Magn Reson       Date:  2011-01-14       Impact factor: 5.364

Review 10.  Clinical Applications of MRA 4D-Flow.

Authors:  Lilia M Sierra-Galan; Christopher J François
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.